Skip to main content

Table 1 PPRV-F, -H and -NP peptide prediction and binding assays to H-2D b and H-2 K b molecules

From: Vaccination with recombinant adenovirus expressing peste des petits ruminants virus-F or -H proteins elicits T cell responses to epitopes that arises during PPRV infection

 

PPRV protein (position)

Sequence

Predicted allele binding

Score SYFPEITHI

Score ProPred-I

Score NetMHC (predicted affinity nM)

Binding assay scorea

F1

F(53–61)

KLMPNITAI

Db

23

138.312

365.28

++

F2

F(135–143)

QSLMNSQAI

Db

25

3281.040

34.37

++

F3

F(369–377)

GTTSNRFIL

Db

19

286.272

3413.74

+

F4

F(342–350)

NALYPMSPL

Db

16

30.240

1927.14

−

Kb

18

0.330

791.56

+++

F5

F(435–443)

SVYLHKIDL

Kb

11

0.100

68.79

+

F6

F(278–286)

IAYPTLSEI

Db

18

4.234

3403.64

+

Kb

9

1.650

168.59

+

F7

F(7–21)

LVFLFLFPNTVTCQI

I-Ab

NA

NA

79.2

NA

F8

F(117–131)

VALGVATAAQITAGV

I-Ab

NA

NA

192.1

NA

F9

F(341–355)

QNALYPMSPLLQECF

I-Ab

NA

NA

351.5

NA

F10

F(284–298)

LSEIKGVIVHKIEAI

Homologue to morbillivirus epitope [38, 39]

NA

NA

5014.3 (I-Ab)

NA

H1

H(270–278)

FHMTNYLTV

Db

21

17.280

43.88

+++

H2

H(158–166)

AAVKSVEHI

Db

21

50.168

593.13

+++

H3

H(547–555)

RSSSYFYPV

Kb

18

1.100

70.29

++

H4

H(549–557)

SSYFYPVRL

Kb

18

5.500

8.75

+++

H5

H(551–559)

YFYPVRLNF

Db

7

0.000

42 098.88

+

Kb

7

0.120

1250.29

−

H6

H(44–52)

VMFLSLIGL

Db

15

14.334

6563.96

++

Kb

11

2.000

44.36

+++

H7

H(426–434)

VITSVFGPL

Kb

21

12.000

96.10

+++

H8

H(441–455)

MDLYNNPFSRAAWLA

I-Ab

NA

NA

42.2

NA

H9

H(427–441)

ITSVFGPLIPHLSGM

I-Ab

NA

NA

74.8

NA

H10

H(448–462)

FSRAAWLAVPPYEQS

I-Ab

NA

NA

319.6

NA

NP1

NP(29–37)

RGIKNVIIV

Db

19

38.880

265.97

+++

NP2

NP(72–80)

VMISMLSLF

Db

18

36.318

3827.32

−

Kb

11

0.030

97.12

+++

NP3

NP(294–302)

STIESLMNL

Db

18

12.773

7155.04

−

Kb

12

1.320

117.94

++

NP4

NP(335–343)

YAMGVGVEL

Db

16

30.240

6163.56

+

NP5

NP(354–362)

RSYFDPAYF

Db

11

0.091

4399.92

−

Kb

8

0.158

1703.38

−

NP6

NP(228–236)

SLRRFMVSL

Kb

12

0.264

184.41

++

NP7

NP(298–306)

SLMNLYQQL

Kb

22

26.400

85.56

+

NP8

NP(435–449)

REEVKAAIPNGSEGR

I-Ab

NA

NA

95.2

NA

NP9

NP(327–341)

GAYPLLWSYAMGVGV

I-Ab

NA

NA

290.8

NA

NP10

NP(176–190)

ILLAKAVTAPDTAAD

I-Ab

NA

NA

355.6

NA

  1. NA: not available, +++ strong binder (ratio > 0.9), ++ moderate binder (0.7 < ratio < 0.9), + weak binder (0.5 < ratio < 0.7), − no binder (ratio < 0.5).
  2. aPeptide score was ranked relative to LCMV gp33-41 peptide binding (ratio PPRV peptide MFI vs gp 33–41 MFI) [32].